| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |